Kim B. Nemirow


  • JD, cum laude, Northwestern University School of Law, 2003
  • BA (Public Policy), Brown University, 1997


  • Illinois, 2017
  • District of Columbia, 2010
  • Massachusetts, 2006
  • New York, 2004
  • Honorable Faith S. Hochberg, U.S. District Court for the District of New Jersey (2004 - 2005)
  • Spanish

In 2013, Kim founded the Hong Kong chapter of the Women’s White Collar Defense Association, a global coalition of women attorneys and other professionals with relevant expertise who specialize in white collar criminal defense. She also spearheaded the Ropes & Gray Women’s Forum initiative for the firm’s offices in Asia (Hong Kong, Shanghai, Tokyo and Seoul) to build a mentoring community for women in the workplace.

Prior to law school, Kim taught elementary school in New York City as a Teach For America corps member and taught for a year in Guatemala.

  • Chambers Asia Pacific 2016: Leading Lawyer
  • Legal 500 Asia-Pacific: Leading Individual in Regulatory: Anti-Corruption/Compliance (2016)
  • Chambers Global: The World's Leading Lawyers for Business (2015-2016)
  • Chambers Asia 2015: Up & Coming (2015)
  • Global Investigations Review “40 under 40” (2014)
  • Financial Times US Innovative Lawyers Report 2013 - Recognized Ropes & Gray’s web-based econometric Risk Matrix tool, developed by the firm’s anti-corruption and international risk team, as a “standout” product
  • Euromoney LMG Women in Business Law -"Rising Star" (2013)

Kim B. Nemirow


Kim is a partner in Ropes & Gray’s Chicago office. Having recently returned to the U.S. after several years in Ropes & Gray’s Hong Kong office, she devotes her practice to white collar matters in Asia, Latin America, and globally. She has extensive experience advising multinational organizations and individuals in a wide variety of U.S. DOJ and SEC investigations, internal investigations, and compliance matters. Kim has led many investigations for private equity, pharmaceutical, medical device, technology and other clients into potential violations of the FCPA, securities laws, and various health care fraud statutes. Kim is also regularly called upon by clients to advise regarding anti-corruption, sanctions and anti-money laundering risk assessments and due diligence matters throughout Asia and Latin America, and to conduct compliance trainings of personnel around the world.

Additionally, Kim is a member of the supply chain compliance and corporate responsibility practice, and regularly advises private equity firms and public companies on a broad range of ESG factors including environmental and social matters and governance.


  • Represented a global medical technologies company in an investigation into potential kickback and cartel-related conduct by one of its Mexican distributors.
  • Advised Blackstone in its joint venture with China Vanke, China’s largest residential developer. Named “Real Estate & Construction Deal of the Year” for 2015 by China Law and Practice.
  • Advised Blackstone in the acquisition of Hindustan Construction’s stake in 247 Park, a large commercial property in the transit hub of Vikhroli, a suburb of Mumbai. Named “Deal of the Year” for 2015 by the India Business Law Journal.
  • Represented multiple multinational pharmaceutical, medical device, technology, real estate and other companies in anti-corruption investigations in China, India, Vietnam, Korea, Japan and elsewhere.
  • Led dozens of anti-corruption, sanctions and anti-money laundering due diligence matters in connection with private equity and other investments in high risk countries around the world, including in China, Brazil, India, and Russia.
  • Representing a global technology company in a government-facing investigation into its promotional practices in China.
  • Represented a global financial institution in an industry-wide FCPA investigation focusing on interactions with Sovereign Wealth Funds.
  • Conducted an internal investigation on behalf of a global investment bank into hiring issues in China.
  • Led anti-corruption risk assessments for more than 100 private equity portfolio companies around the world, including companies in China, India, Central and South America, Europe, and Africa.
  • Developed and implemented anti-corruption compliance programs for several private equity firms and their global portfolio companies.
  • Represented multiple major medical device manufacturers in federal criminal investigations into the companies’ marketing practices and relationships with physicians.
  • Achieved a dismissal of a False Claims Act action alleging improper marketing practices against a multinational medical device manufacturer.
  • Represented a major pharmaceutical company in several multi-defendant consumer protection actions brought by states’ attorneys general regarding Medicaid pricing fraud.



  • Presenter, “Panama Papers Revisited: One Year Later,” American Bar Association’s spring 2017 meeting, Washington, D.C. (April 28, 2017)
  • Keynote Speaker, “Diploma on Anticorruption,” ICC Mexico in collaboration with Law School of Panamerican University (February 2, 2017)
  • Presenter, “Discovery Issues in Chinese Litigations,” Consilio, Fordham Law, New York, NY (January 24, 2017)
  • Presenter, “The Changing U.S. Political and Enforcement Environment and the Impact on Compliance,” ICC Mexico, Mexico City (November 29, 2016)
  • Moderator, “Perspectives on Anti-Corruption Compliance and Enforcement Challenges in China,” Ropes & Gray Roundtable, Chicago (September 26, 2016)
  • Panelist, “Anti-Corruption Developments in Latin America & Beyond: Managing the Mounting Compliance Concerns in Latin America,” The Hispanic National Bar Association Annual Convention, Chicago (September 8, 2016)
  • Speaker, “What You Need to Know to Protect Your Business after the Panama Papers: A Cross-Practice Discussion,” Ropes & Gray Webinar (June 29, 2016)
  • Presenter, “Tendencias de FCPA en América Latina para Empresas Farmacéuticas,” Cámara Argentina de Especialidades Medicinales, Buenos Aires, Argentina (May 27, 2016)
  • Panelist, “Conducting an Effective Internal Investigation in the Lava Jato Era and Reflections on an Effective Compliance Program,” Demarest Advogados, São Paulo, Brazil (May 23, 2016)
  • Panelist, “Exploring the Career and Leadership Issues Raised in Lean-In: Women, Work and the Will to Lead by Sheryl Sandberg, Women’s luncheon, São Paulo, Brazil (May 23, 2016)
  • Panelist, “The Foreign Corrupt Practices Act and International Anti-Corruption Developments 2016,” Practising Law Institute, New York (May 2016)
  • Panelist, “Compliance, Ethics and Enforcement on International Trade Program,” The John Marshall Law School’s Center for International Law’s conference, Chicago (April 2016)
  • Panelist, “Chicago Foreign Corruption Conference,” 9th Annual Chicago White Collar Crime and Corporate Governance Conference, Chicago (April 2016)
  • Panelist, “Crisis Communication: Handling Communications as Part of a Litigation Strategy ,”FTI Consulting and Ropes & Gray Roundtable, New York (November 2015)
  • Presenter, “Effective Monitoring and Risk Assessment,” Joint AdvaMed and APACMed Compliance Meeting, Singapore (July 2015)
  • Panelist, “How to Update and Localise your Global Anti-Corruption Programme to Protect Against the Unique Pitfalls and Risks of Operating in China,” at C5’s 3rd Annual Australian Anti-Corruption, Compliance & risk Management Summit (May 2015)
  • Presenter, “Focus on China’s Commercial Bribery Crackdown,” American Conference Institute’s 3rd Asia-Pacific Summit on Anti-Corruption, Compliance and Risk Management, Singapore (December 2014)
  • Presenter, “Developments in International Anti-Corruption Law — Recent Enforcement Trends and Common Risk Areas in Asia,” Ropes & Gray Teleconference Briefing, Tokyo (September 2014)
  • Presenter, “Lessons Learned Conducting Investigations in China,” Ropes & Gray Government Enforcement Roundtable, Hong Kong (September 2014)
  • Presenter, “U.S. Antitrust & Anti-Corruption Enforcement,” Ropes & Gray Seminar co-hosted with The Japanese Institute of International Business Law, Tokyo (June 2014)
  • Moderator, “The 2014 Anti-corruption Environment: What it Means for Doing Business in China,” Chambers and Partners General Counsel Seminar in association with Ropes & Gray, Hong Kong (February 2014)
  • Presenter, “Distributor Management: Anti-corruption Risks and Best Practices,” Ropes & Gray Medical Device Roundtable: Distributor Management and Medical Device Tendering (July 2013)
  • Panelist, “How to Establish an Effective Third Party Monitoring Program,” American Conference Institute’s 6th China Summit on Anti-Corruption (June 2013)
  • Presenter, “Navigating the FCPA “Resource Guide”: Enforcement Trends and Compliance Tips,” Ropes & Gray webinar (November 2012)